Loading...
TrendSpott

TrendSpott

TrendSpott
 
 
Agenus
1.52
+4.83%
 
Recommendation
AGEN Agenus
  Login
 
 
Last Price
 
Change
 
1.52
 
+4.83%
 
 

 
Sentiment
 
  Login to display
 
 

2.07

2.4

3.04

2.44

 
 
1m
3m
6m
1y
 

Summary

  Login to display Agenus (AGEN) recommendation from the last 90 days from financial news and social media.
 

Rewards

Rewards

 Earnings are forecast to grow

Rewards

 Insider buying over the past 3 months

 
 

Risk Level

 
TrendSpott
 

Agenus (AGEN) has High Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 
Earnings ×
 

Earnings

2.67
 

TrendSpott

 Reported a weak earnings

 
 
Rating ×
 

Rating

NA
 
 
Momentum ×
 

Momentum

3.00
 
 
Activity ×
 

Activity

3.71
 

TrendSpott

 Insider buying over the past 3 months

 
Future ×
 

Future

5.00
 

TrendSpott

 Earnings are forecast to grow

 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
76%
NA
50%
100%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is extremely ish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
76%
20%
Positive
Negative
19 out of 25
events present
5 out of 25
events present
 

 
Events Calendar
Click for more information
 
February
S
M
T
W
T
F
S
March
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change
 
Weak Earnings
2 Weeks Ago
1.79
+4.68%
 
Investors Activity
2 Month Ago
2.22
-3.90%
 
Insider Buying
3 Month Ago
2.64
+11.39%
 
Top Headlines

agenus investigational cancer combo therapy shows 33% durable responses in ovarian cancer. )from a cohort of 24 evaluable patients in an expansion o

Mon Mar 27, 2023

Activity

why agenus stock is slumping this week. what happened shares of the clinical-stage immunotherapy company agenus (nasdaq: agen) fell by 11.7% during the first three and half days of trading this week according to data provided by s&p global mark

Thu Mar 23, 2023

Momentum

agenus readies comeback with impressive botensilimab data.

Tue Mar 21, 2023

Potential

agenus (agen) reports q4 loss tops revenue estimates. agenus (agen) came out with a quarterly loss of $0.24 per share versus the zacks consensus estimate of a loss of $0.22. this compares to loss of $0.26 per share a year ago. these fi

Tue Mar 14, 2023

Earnings
Earnings

agenus extends gains after q4 2022 results.

Tue Mar 14, 2023

Momentum

agenus gaap eps of -$0.24 misses by $0.02 revenue of $28.39m beats by $10.56m.

Tue Mar 14, 2023

Earnings

earnings preview for agenus. ) is set to give its latest quarterly earnings report on tuesday 2023-03-14. here'.s what investors need to know before the announcement. analysts estimate that agenus will report an agenus s will hope to hear the compa

Mon Mar 13, 2023

Activity

agenus (agen) investor presentation - slideshow.

Fri Feb 10, 2023

Activity

agenus updated data confirms long-term potential value.

Tue Jan 24, 2023

Potential

chief medical officer of agenus purchased $267k in stock. ) reported a large insider buy on january 9 according to a new sec filing. United States securities and exchange comm

Tue Jan 10, 2023

Activity

agenus recent insider activity. ) reported a large insider buy on january 9 according to a new sec filing. United States securities and exchange comm

Tue Jan 10, 2023

Activity

agenus chairman and ceo trades companys stock. ) reported a large insider buy on january 9 according to a new sec filing. United States securities and exchange commissi

Tue Jan 10, 2023

Activity

 
 
 
TrendSpott

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

TrendSpott on Twitter TrendSpott on YouTube TrendSpott on stocktwits TrendSpott Rss
 

Receive our daily AGEN alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by TrendSpott including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
TrendSpott

TrendSpott

Get the pulse of the market

 
TrendSpott

TrendSpott

AGEN Agenus

Last Price
1.52
Change
+4.83%
Recommendation
  Login to display
 

Summary

  Login to display Agenus (AGEN) recommendation from the last 90 days from financial news and social media.

 
 
2.07
2.4
3.04
2.44
 
 
1m
3m
6m
1y
 
Sentiment
 

  Login to display

Rewards

Rewards

 Earnings are forecast to grow

Rewards

 Insider buying over the past 3 months

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
NA
50%
100%
On Track
On Track
On Track
 
76%
20%
Positive
Negative
19 out of 25
events present
5 out of 25
events present
 

Street Opinion

Street view is extremely ish and have positive views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 
Earnings ×
 

Earnings

2.67
 

TrendSpott

 Reported a weak earnings

 
 
Rating ×
 

Rating

NA
 
 
Momentum ×
 

Momentum

3.00
 
 
Activity ×
 

Activity

3.71
 

TrendSpott

 Insider buying over the past 3 months

 
Future ×
 

Future

5.00
 

TrendSpott

 Earnings are forecast to grow

 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 
 
 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Risk Level
 
TrendSpott
 

Agenus (AGEN) has High Risk Level.  Click here to check what is your level of risk

 
 
 

Events Calendar

Hover for information

 
February
 
S
M
T
W
T
F
S
 
March
 
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change
 
Weak Earnings
2 Weeks Ago
1.79
+4.68%
 
Investors Activity
2 Month Ago
2.22
-3.90%
 
Insider Buying
3 Month Ago
2.64
+11.39%
 
 
 
TrendSpott

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

TrendSpott on Twitter TrendSpott on YouTube TrendSpott on stocktwits TrendSpott Rss

 

Receive our daily AGEN Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by TrendSpott including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines